Hernia Repair Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Hernia Repair Devices Market is projected to expand from USD 6.45 Billion in 2025 to USD 7.78 Billion by 2031, achieving a CAGR of 3.17%. These devices consist of specialized surgical meshes and fixation systems used to reconstruct or reinforce tissue walls during herniorrhaphy procedures. Growth in this sector is primarily fueled by an aging population and rising obesity rates, both of which increase physiological susceptibility to abdominal wall defects. Additionally, the continued transition toward minimally invasive laparoscopic and robotic-assisted surgeries is accelerating the demand for advanced biologic and synthetic repair materials.

However, market expansion faces headwinds due to persistent scrutiny regarding post-operative complications and litigation involving synthetic mesh implants, which can delay regulatory approvals and impact clinical adoption. Despite these regulatory challenges, procedural volumes remain high within established healthcare systems, ensuring a steady demand for repair devices. For instance, the Royal College of Surgeons of England reported that in 2024, hernia repair remained one of the most frequent surgical interventions, with more than 120,000 operations performed annually across the United Kingdom.

Market Drivers

Technological progress in robotic and laparoscopic platforms is significantly reshaping the market by facilitating greater precision and faster patient recovery. This trend toward minimally invasive techniques is particularly visible in the rise of general surgery volumes, where robotic systems are increasingly becoming the standard for complex abdominal wall reconstructions. According to Intuitive Surgical’s preliminary results from January 2025, worldwide da Vinci procedures increased by approximately 17% in 2024, a growth largely driven by general surgery applications in the United States. This technological adoption supports a substantial procedural workload, with TELA Bio noting in 2025 that hernia repairs remain a leading surgery in the U.S., accounting for roughly 1.5 million annual procedures.

Simultaneously, innovation in biologic and bioabsorbable mesh materials is driving market momentum as surgeons aim to reduce chronic inflammatory responses associated with permanent synthetic implants. These advanced matrices are engineered to support natural tissue remodeling and minimize the risk of recurrence, addressing a critical need for high-risk patient groups. The commercial success of these hybrid scaffolds highlights a decisive shift toward anatomy-preserving materials. As reported by Fierce Biotech in December 2025, TELA Bio announced full-year 2024 revenue of $69.3 million, representing a 19% increase attributed to the demand for its OviTex reinforced biologic mesh portfolio.

Market Challenges

The ongoing scrutiny regarding post-operative complications and legal disputes associated with synthetic mesh implants presents a significant barrier to entry and expansion in the Global Hernia Repair Devices Market. Manufacturers are compelled to meet rigorous clinical evidence standards to mitigate liability risks, a requirement that drastically inflates research and development costs while extending approval timelines. This challenging regulatory environment forces companies to divert capital toward legal defense and compliance rather than innovation, resulting in a deceleration in the commercialization of next-generation herniorrhaphy devices.

These regulatory pressures directly reduce regional market attractiveness and product availability. Data from MedTech Europe in 2024 indicates that the percentage of large medical device manufacturers choosing the European Union as their initial launch geography fell by 33 percent due to the complexities of meeting heightened safety and performance requirements. This trend illustrates how regulatory stringency, driven by safety concerns, effectively limits the volume of new products reaching established healthcare systems. By stifling the introduction of advanced technologies, the market experiences slower revenue turnover and reduced procedural adoption rates for novel repair materials.

Market Trends

The migration of hernia repair procedures to Ambulatory Surgical Centers (ASCs) is fundamentally changing the site-of-care landscape for abdominal wall reconstruction. Payors and healthcare systems are actively incentivizing the shift of intermediate-acuity surgeries, such as inguinal and ventral hernia repairs, from hospital inpatient departments to outpatient facilities to enhance cost-efficiency and procedural turnover. This structural transition is supported by substantial revenue growth in dedicated surgical divisions of major health systems. For example, ASC News reported in February 2025 that Tenet Healthcare’s United Surgical Partners International (USPI) division achieved full-year 2024 net operating revenues of $4.5 billion, a 15.4% increase driven largely by the volume shift of high-acuity cases to ambulatory settings.

Concurrently, there is a surging demand for biologic and biosynthetic mesh implants, particularly those utilizing advanced polymer technologies like poly-4-hydroxybutyrate (P4HB). Unlike traditional biologics often reserved for complex reconstructions in high-risk patients, newer biosynthetic platforms are entering the market for routine defects, such as umbilical hernias, offering resorbable scaffolds that provide temporary strength without leaving permanent foreign material. This adoption is evidenced by the commercial scaling of next-generation absorbable portfolios. As noted by Xtalks in April 2025, Becton, Dickinson and Company launched a new P4HB patch and announced that its bioabsorbable Phasix Mesh portfolio has now surpassed 385,000 implants globally.

Key Players Profiled in the Hernia Repair Devices Market

• Medtronic plc
• Ethicon Inc.
• Beckton Dickinson & Co,
• Atrium
• W. L. Gore & Associates, Inc.
• LifeCell International Pvt. Ltd.
• B. Braun SE
• Baxter International Inc.
• Cook Medical Inc.
• Herniamesh S.r.l.

Report Scope

In this report, the Global Hernia Repair Devices Market has been segmented into the following categories:

Hernia Repair Devices Market, by Product Type:

• Hernia Mesh
• Hernia Fixation Devices

Hernia Repair Devices Market, by Procedure Type:

• Open Surgery
• Laparoscopic Surgery

Hernia Repair Devices Market, by Surgery Type:

• Inguinal Hernia
• Umbilical Hernia
• Incisional Hernia
• Femoral Hernia
• Others

Hernia Repair Devices Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hernia Repair Devices Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.